Skip to main content

Month: August 2022

Grieg Seafood ASA: Presentation of second quarter 2022 results

Grieg Seafood ASA will release its second quarter 2022 results on Tuesday, August 23, 2022 at 6:00 a.m. CEST. CEO Andreas Kvame and CFO Atle Harald Sandtorv will present the results live at Hotel Continental, Stortingsgaten 24/26, Oslo, and by webcast the same day at 9:00 a.m. CEST. The presentation and the subsequent Q&A will be held in Norwegian. The presentation can be accessed at https://investor.griegseafood.com/reports-&-presentations#quarterly or with the following link: https://channel.royalcast.com/landingpage/hegnarmedia/20220823_2/For further enquiries, please contact: Andreas Kvame, CEO Cell phone: +47 907 71 441 Atle Harald Sandtorv, CFO Cell phone +47 908 45 252About Grieg Seafood Grieg Seafood ASA is one of the world’s leading salmon farmers. Our farms are in Finnmark and Rogaland in Norway, and British...

Continue reading

Mainz Biomed and Dante Genomics Announce Full Commercial Availability of ColoAlert in Italy and the United Arab Emirates

ColoAlert to be marketed through Dante’s extensive database and sold via its region-specific, ecommerce websites BERKELEY, Calif. and MAINZ, Germany and NEW YORK, Aug. 16, 2022 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, and Dante Genomics, a global leader in genomics and precision medicine, announced today the formal commencement of ColoAlert’s consumer commercial program in Italy and the United Arab Emirates (UAE). ColoAlert is Mainz’s flagship product, a highly efficacious and easy to use, at-home detection test for colorectal cancer (CRC) currently being commercialized across Europe and select international markets. With the ColoAlert test CE-IVD certified and patient collection kit CE marked to the...

Continue reading

Governance of AB “Ignitis grupė” subsidiaries is optimised

The Supervisory Board and the Management Board of AB “Ignitis grupė” (hereinafter – the Group) have adopted decisions to replace a two-tier management model applicable in the Group’s main subsidiaries AB “Energijos skirstymo operatorius”, AB “Ignitis gamyba” and UAB “Ignitis” (hereinafter – the Subsidiaries) with a one-tier management model, i.e. to remove the Executive Boards made up of employees and instead to form Boards with a supervisory function that will be made up of at least 1/3 of independent members, civil servants and shareholder representatives. These Boards will have a duty to perform supervisory functions for the above-mentioned companies and therefore the Supervisory Boards currently operating in the Subsidiaries will be removed. UAB “Ignitis renewables” already applies a one-tier governance model and therefore it will...

Continue reading

Governance of AB “Ignitis grupė” subsidiaries is optimised

The Supervisory Board and the Management Board of AB “Ignitis grupė” (hereinafter – the Group) have adopted decisions to replace a two-tier management model applicable in the Group’s main subsidiaries AB “Energijos skirstymo operatorius”, AB “Ignitis gamyba” and UAB “Ignitis” (hereinafter – the Subsidiaries) with a one-tier management model, i.e. to remove the Executive Boards made up of employees and instead to form Boards with a supervisory function that will be made up of at least 1/3 of independent members, civil servants and shareholder representatives. These Boards will have a duty to perform supervisory functions for the above-mentioned companies and therefore the Supervisory Boards currently operating in the Subsidiaries will be removed. UAB “Ignitis renewables” already applies a one-tier governance model and therefore it will...

Continue reading

2022 no. 10 – Notice of extension of offer period

Aalborg, 16 August 2022 Notice of extension of offer period Ahlsell Danmark ApS (“Ahlsell”) extends the offer period of the offer to the holders of approx. 24.51% af the shares in Sanistål A/S (“Sanistål”). On 24 May 2022, Ahlsell announced that Ahlsell had entered into conditional share purchase agreements with Danske Bank A/S, Nordea Bank Abp, Jyske Bank A/S and Nykredit Bank A/S (the “Major Shareholders”) to acquire approximately 75.49% of the shares in Sanistål at a price of DKK 58 per share. In addition, Ahlsell announced that they would make a recommended conditional voluntary public offer (the “Offer”) to purchase the remaining approximately 24.51% of the shares held by all shareholders other than the Major Shareholders at a price of DKK 85 per share, please refer to company announcement...

Continue reading

OKYO Pharma Limited – Final audited results for the year ended 31 March 2022

LONDON and NEW YORK, Aug. 16, 2022 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO; LSE: OKYO) (the “Company”) is pleased to announce its final audited results for the year ended 31 March 2022. Summary of OKYO-101 studies during the last yearOK-101 is designed to target a chemokine-like receptor 1, or CMKLR1, which is a G protein-coupled receptor, or GPCR, expressed on macrophages, monocytes, plasmacytoid/myeloid dendritic cells, natural killer cells and nonhemopoietic cell types, such as endothelial and epithelial cells. Activation of CMKLR1 by its endogenous peptide ligand chemerin is known to modulate inflammation, but natural ligands for CMKLR1 have short half-lives due to rapid inactivation. A major issue with topical administration of any drug designed for treating DED is the requirement that the drug have adequate...

Continue reading

Condor Gold plc announces its unaudited results for the six months ended 30 June 2022

GODALMING, United Kingdom, Aug. 16, 2022 (GLOBE NEWSWIRE) — Condor Gold (AIM: CNR; TSX: COG) announces that it has today published its unaudited financial results for the six months ending 30 June 2022 and the Management’s Discussion and Analysis for the same period. Both of the above have been posted on the Company’s website www.condorgold.com and are also available under the Company’s SEDAR profile at www.sedar.com. Highlights for the three and six months to 30 June 2022:On March 10, 2022, the Company announced that all assay results have been received for an 8,004 m infill drilling programme on the fully permitted high-grade La Mestiza Open Pit Mineral Resource at La India Project.6.3 m true width at 6.84 g/t gold from 31.45 m (drill hole LIDC568), approximately 50 m below surface outcrop (which occurs on a rise). 4.1 m...

Continue reading

Jyske Realkredit A/S – Interim Financial Report, first half of 2022

Jyske Realkredit A/S – Interim Financial Report, first half of 2022 To NASDAQ Copenhagen A/S                                                                                                                  16 August 2022                                                                                                                 Announcement No. 90/2022 Interim Financial Report, first half of 2022 On August 16, 2022 the Supervisory Board has approved the Interim Financial Report, first half of 2022 of Jyske Realkredit A/S. Please see attached file. Yours sincerely,Jyske Realkredit A/S Carsten Tirsbæk MadsenCEO Direct phone (+45) 89 89 90 50E-mail: ctm@jyskerealkredit.dk Web: jyskerealkredit.dk Please observe that the Danish version of this announcement prevails. Attached files:Interim Financial Report of Jyske Realkredit, Q2 2022.pdf...

Continue reading

Proactive news headlines including Nexus Minerals, Chase Mining Corporation, Emyria Ltd and Horizon Minerals

Sydney, Aug. 16, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:Nexus Minerals Ltd (ASX:NXM) is a well-funded resource company with a portfolio of gold projects in Western Australia and a well-credentialed board, assisted by an experienced management team. Click here Chase Mining Corporation Ltd (ASX:CML) continues to progress the agreement to acquire Green Critical Minerals Pty Limited (GCM) which holds rights to acquire up to 80% of the McIntosh Graphite Project, Australia’s third-largest ASX-listed graphite project. Click here Emyria Ltd (ASX:EMD) is set to commence a pivotal Phase 3 clinical trial of its Ultra-Pure Cannabidiol (CBD) candidate, EMD-RX5, for the treatment of psychological distress after receiving...

Continue reading

Interim Financial Report, H1 2022

Earnings per share DKK 24.5 (H1 2021: DKK 22.2)For 2022, it is anticipated that earnings per share will be at the upper end of the range of DKK 44-50, and a net profit is expected at the upper end of the range of DKK 3.0 bn – 3.4 bnNet interest income: DKK 2,671m (H1 2021: DKK 2,454m)Net fee and commission income: DKK 1,250m (H1 2021: DKK 1,085m)Value adjustments: DKK -84m (H1 2021: DKK 605m)Core income: DKK 4,197m (H1 2021: DKK 4,364m)Core expenses: DKK 2,355m (H1 2021: DKK 2,342m), of which one-off expenses of DKK 11m due to the acquisition of Handelsbanken’s activities in DenmarkLoan impairment charges: DKK -247m (H1 2021: DKK -37m)Net profit: DKK 1,691m, corresponding to a return on equity of 9.2% p.a. (H1 2021: DKK 1,685m and 9.4% p.a.)Common equity tier 1 capital ratio: 17.9 (H1 2021: 18.3)The...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.